CVS to sell its troubled long-term care pharmacy
GenieRx→Omnicare
May 14, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Shyld AI has completed the acquisition of Shyld AI, a medical devices business in California, for $13.4 million. Shyld AI develops an AI-powered UV disinfection platform that autonomously sanitizes hospital rooms to help reduce hospital-acquired infection risk and improve cleaning consistency. The system is designed to lower reliance on labor-intensive environmental services workflows in healthcare facilities across California. This other acquisition supports Shyld AI expansion with a healthcare M&A strategy focused on scaling autonomous medical device deployment, with deal size reported at $13.4 million and an announced status.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
GenieRx→Omnicare
May 14, 2026
Amarox→CEL-SCI
May 14, 2026
Create Medicines
May 14, 2026
Zydus Worldwide DMCC→Assertio Holdings
May 14, 2026
Biogen→Apellis Pharmaceuticals
May 14, 2026